Why Pfizer Stock Just Popped
Pfizer (NYSE: PFE) stock was trading 3.6% higher as of 12:01 p.m. ET Tuesday after The Washington Post reported that the Trump administration had struck a deal with the pharmaceutical giant under which it will sell some drugs to Medicaid patients at reduced prices.
Image source: Getty Images.
President Donald Trump signed an executive order in May ordering the government to negotiate new pricing with U.S. drugmakers, such that they charge no more to U.S. customers than they do to patients in other wealthy nations. Step one of the plan that order laid out involves attempting to get drug companies to lower prices voluntarily -- with the implication that step two might involve the government imposing mandatory price cuts.
Source Fool.com
Pfizer Inc. Aktie
23,33 €
-0,21 %
Leichte Buy-Präferenz bei der Pfizer Inc. Aktie.
Ein positives, wenn auch nicht starkes, Potenzial für Pfizer Inc. mit einem Kursziel von 27 € im Vergleich zu 23.33 €.
